Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shannon Byler, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Agarwal A, Shah A, Byler S, Hirsch AE. Cultivating Interest in Oncology Through a Medical Student Oncology Society. J Cancer Educ. 2017 03; 32(1):31-34. PMID: 26341219.
    Citations: 3     Fields:    Translation:Humans
  2. Lapinska K, Housman G, Byler S, Heerboth S, Willbanks A, Oza A, Sarkar S. The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells. Anticancer Res. 2016 11; 36(11):5731-5742. PMID: 27793894.
    Citations: 5     Fields:    Translation:HumansCells
  3. Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S. EMT and tumor metastasis. Clin Transl Med. 2015; 4:6. PMID: 25852822.
    Citations: 155     
  4. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S. Drug resistance in cancer: an overview. Cancers (Basel). 2014 Sep 05; 6(3):1769-92. PMID: 25198391.
    Citations: 270     
  5. Byler S, Sarkar S. Do epigenetic drug treatments hold the key to killing cancer progenitor cells? Epigenomics. 2014 Apr; 6(2):161-5. PMID: 24811783.
    Citations: 11     Fields:    Translation:HumansCells
  6. Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K, Sarkar S. Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res. 2014 Mar; 34(3):1071-7. PMID: 24596345.
    Citations: 52     Fields:    Translation:HumansAnimals
  7. Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, Longacre M. Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci. 2013 Oct 21; 14(10):21087-113. PMID: 24152442.
    Citations: 55     Fields:    Translation:HumansAnimals
  8. Sarkar S, Goldgar S, Byler S, Rosenthal S, Heerboth S. Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy. Epigenomics. 2013 Feb; 5(1):87-94. PMID: 23414323.
    Citations: 26     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Byler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (28)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.